Marpai, Inc. Secures Additional $5,000,000 Funding for Growth Initiatives TAMPA, Fla., Jan. 6, 2025 /PRNewswire/ — Marpai, Inc. (“Marpai” or the “Company”) (OTCQX: MRAI), a technology platform company, which operates as a national Third-Party Administrator (TPA) through its subsidiaries and is transforming the $22 billion TPA market by offering affordable, intelligent, healthcare solutions to self-funded…
AI’s Impact on Chip Design Innovations The Current Landscape As artificial intelligence continues to advance at a rapid pace, the demand for more powerful and efficient AI chips is on the rise. This has led to a virtuous cycle where the need for better AI technology is driving innovations in chip design, and advancements in…
Welcome to our blog post about Invesco Mortgage Capital Inc. About Invesco Mortgage Capital Inc. Invesco Mortgage Capital Inc. is a Real Estate Investment Trust (REIT) that specializes in mortgage-backed securities and related assets. These assets include residential and commercial mortgage-backed securities, U.S. Treasury securities, and real estate financing arrangements. The company’s investment thesis focuses…
Smart Eye Enters Agreement to License Iris Recognition Technology In a move that highlights their commitment to cutting-edge technology and innovation, Smart Eye has announced a new agreement to license iris recognition technology from Swedish company Fingerprint Cards. The total consideration for this agreement is set at SEK 50 million plus VAT, showcasing the significant…
The Schall Law Firm Reminds Investors of Class Action Lawsuit Against Applied Therapeutics, Inc. Investors’ Rights Alert Los Angeles, CA / Accesswire / January 6, 2025 The Schall Law Firm, a national shareholder rights litigation firm, recently reminded investors of a class action lawsuit against Applied Therapeutics, Inc. This lawsuit alleges violations of 10(b) and…
Shareholder Class Action Lawsuit Filed Against Revance Therapeutics, Inc. ATLANTA, Jan. 06, 2025 (GLOBE NEWSWIRE) A shareholder class action lawsuit has been filed against Revance Therapeutics, Inc. (“Revance” or the “Company”) (NASDAQ: RVNC). The lawsuit alleges that Defendants made materially false and/or misleading statements, and/or failed to disclose material adverse facts about Revance’s business, operations,…
Class Action Lawsuit Filed Against Revance Therapeutics, Inc. Overview NEW YORK, NY / ACCESSWIRE / January 6, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Revance Therapeutics, Inc. (“Revance” or “the Company”) (NASDAQ:RVNC) and certain of its officers. Class Definition…
Dublin, Jan. 06, 2025 (GLOBE NEWSWIRE) — The “Payroll Outsourcing Market Report and Forecast 2024-2032” report has been added to ResearchAndMarkets.com’s offering. The global payroll outsourcing market size reached approximately USD 10.36 billion in 2023. Aided by the increasing demand for efficient payroll management solutions and the growing trend of business process outsourcing, the market…
